Annual Results Results Snapshot
Figures in Rs cr
Consolidate Annual Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Mar'18
Net Sales
770.24
751.59
747.45
577.21
689.31
898.57
815.14
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
770.24
751.59
747.45
577.21
689.31
898.57
815.14
Raw Material Cost
339.12
330.04
385.27
260.26
260.00
216.90
386.23
Purchase of Finished goods
51.35
44.34
34.91
81.34
175.67
401.89
5.47
(Increase) / Decrease In Stocks
-8.35
26.94
-29.20
-11.88
4.30
-6.53
-0.57
Employee Cost
95.58
86.17
76.15
68.09
53.69
42.32
69.23
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
157.15
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
141.92
146.78
161.98
72.75
72.33
86.35
0.50
Total Expenditure (Excl Depreciation)
619.62
634.27
629.11
470.56
565.99
740.93
618.00
Operating Profit (PBDIT) excl Other Income
150.62
117.32
118.34
106.65
123.32
157.64
197.14
Other Income
28.74
17.79
31.49
20.22
39.19
37.63
26.54
Operating Profit (PBDIT)
179.36
135.11
149.83
126.87
162.51
195.27
223.68
Interest
6.91
10.36
4.74
5.51
7.57
4.41
22.80
Exceptional Items
-29.20
0.00
-73.59
0.00
-13.38
0.00
-34.20
Gross Profit (PBDT)
143.25
124.75
71.50
121.36
141.56
190.86
166.68
Depreciation
26.38
18.67
17.33
17.23
12.59
8.94
21.38
Profit Before Tax
116.87
106.07
54.17
104.13
128.97
181.92
145.29
Tax
35.29
29.34
31.04
30.16
33.71
55.25
56.63
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
81.58
76.73
23.13
73.97
95.25
126.66
88.66
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
81.58
76.73
23.13
73.97
95.25
126.66
88.66
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-6.12
-5.88
-8.09
-5.48
2.01
-2.94
-29.88
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
75.45
70.86
15.04
68.49
97.27
123.72
58.79
Equity Capital
10.47
10.42
10.37
10.31
10.31
10.31
10.32
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
956.72
873.48
808.33
797.94
725.30
635.68
0.00
Earnings per share (EPS)
7.21
6.8
1.45
6.64
9.43
12.0
5.7
Diluted Earnings per share
7.11
6.72
1.43
6.49
9.43
11.99
5.7
Operating Profit Margin (Excl OI)
19.55%
15.61%
15.83%
18.48%
17.89%
17.54%
24.18%
Gross Profit Margin
18.6%
16.6%
9.57%
21.03%
20.54%
21.24%
20.45%
PAT Margin
10.59%
10.21%
3.09%
12.82%
13.82%
14.1%
10.88%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2024 is 2.48% vs 0.55% in Mar 2023
Consolidate Net Profit
YoY Growth in year ended Mar 2024 is 6.48% vs 371.14% in Mar 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2024 is 28.38% vs -0.86% in Mar 2023
Interest
YoY Growth in year ended Mar 2024 is -33.30% vs 118.57% in Mar 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2024 has improved from Mar 2023
Compare Annual Results Of Bliss GVS Pharma With
Figures in Rs cr
Consolidate Annual Results
Change(INR)
Change(%)
Net Sales
770.24
10,334.77
-9,564.53
-92.55%
Other Operating Income
0.00
0.00
0.00
Total Operating income
770.24
10,334.77
-9,564.53
-92.55%
Raw Material Cost
339.12
1,853.52
-1,514.40
-81.70%
Purchase of Finished goods
51.35
1,409.85
-1,358.50
-96.36%
(Increase) / Decrease In Stocks
-8.35
-53.67
45.32
84.44%
Employee Cost
95.58
2,274.73
-2,179.15
-95.80%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
141.92
2,315.28
-2,173.36
-93.87%
Total Expenditure (Excl Depreciation)
619.62
7,799.71
-7,180.09
-92.06%
Operating Profit (PBDIT) excl Other Income
150.62
2,535.06
-2,384.44
-94.06%
Other Income
28.74
280.86
-252.12
-89.77%
Operating Profit (PBDIT)
179.36
2,815.92
-2,636.56
-93.63%
Interest
6.91
33.53
-26.62
-79.39%
Exceptional Items
-29.20
0.00
-29.20
Gross Profit (PBDT)
143.25
2,782.39
-2,639.14
-94.85%
Depreciation
26.38
398.25
-371.87
-93.38%
Profit Before Tax
116.87
2,384.14
-2,267.27
-95.10%
Tax
35.29
457.58
-422.29
-92.29%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
81.58
1,926.56
-1,844.98
-95.77%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
81.58
1,926.56
-1,844.98
-95.77%
Share in Profit of Associates
0.00
15.21
-15.21
-100.00%
Minority Interest
-6.12
-28.87
22.75
78.80%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
75.45
1,912.90
-1,837.45
-96.06%
Equity Capital
10.47
40.06
-29.59
-73.86%
Face Value
1.00
1.00
0.00
Reserves
956.72
9,323.03
-8,366.31
-89.74%
Earnings per share (EPS)
7.21
47.75
-40.54
-84.90%
Diluted Earnings per share
7.11
47.68
-40.57
-85.09%
Operating Profit Margin (Excl OI)
19.55%
24.53%
0.00
-4.98%
Gross Profit Margin
18.60%
26.92%
0.00
-8.32%
PAT Margin
10.59%
18.79%
0.00
-8.20%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 770.24 Cr
in Mar 2024Figures in Rs Cr
YoY Growth in year ended Mar 2024 is 2.48% vs 0.55% in Mar 2023
Annual - Consolidate Net Profit
Consolidate Net Profit 75.45 Cr
in Mar 2024Figures in Rs Cr
YoY Growth in year ended Mar 2024 is 6.48% vs 371.14% in Mar 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 150.62 Cr
in Mar 2024Figures in Rs Cr
YoY Growth in year ended Mar 2024 is 28.38% vs -0.86% in Mar 2023
Annual - Interest
Interest 6.91 Cr
in Mar 2024Figures in Rs Cr
YoY Growth in year ended Mar 2024 is -33.30% vs 118.57% in Mar 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 19.55%
in Mar 2024Figures in Rs %
YoY Growth in year ended Mar 2024 has improved from Mar 2023
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
